Strength Training Exercise for Pediatric Leukemia

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

Recruiting N/A Interventional Study
Leukemia Acute Leukemia Acute Lymphoid Leukemia Lymphoblastic Lymphoma Acute Lymphoblastic Leukemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
40 (estimated)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Other
Who this trial is looking for

This trial is looking for children aged 6 to 21 who have recently been diagnosed with acute lymphoblastic leukemia or lymphoblastic lymphoma. Participants will take part in a structured exercise program to help improve their health during treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 6 and 21 years old.
  • I have a new diagnosis of B-cell or T-cell acute lymphoblastic leukemia.
  • I have a new diagnosis of lymphoblastic lymphoma.
  • I have the consent of my parent or legal guardian to participate.

You may not be able to join if

  • I am receiving investigational or additional anti-cancer medicines.
  • I have a significant illness or psychiatric disorder that can affect my safety or participation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and, along with lymphoblastic lymphoma, represents the most common group of childhood lymphoid malignancies. Survival rates have improved over the years, but many children still experience long-term side effects from treatment. These can include tiredness, weak muscles, pain, nerve problems, difficulty moving, and other physi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for children: All subjects must meet the following criteria: * Written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information. OR Written assent and parental/legal guardian consent. * Age \>= 6 and \< =21 years at…
Contacts

Jessica Buddenbaum, MS

919-966-4432

jessica_buddenbaum@med.unc.edu

CONTACT

Juanita Cuffee

919-216-0463

cuffee@med.unc.edu

CONTACT